Showing results (21-30 of 24) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
ESMO Open|January 4, 2025
Results of a patient-level pooled analysis of three studies of trastuzumab deruxtecan in HER2-positive breast cancer with active brain metastasisR Bartsch, J M Pérez-García, J Furtner, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2020
Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancerA G Waks, O Cohen, B Kochupurakkal, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2024
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022R A Freedman, H M Heiling, T Li, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2026
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancerA C Garrido-Castro, S E Kim, T Li, et al.Pageof 3